GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹584 Cr | ₹557 Cr | ₹612 Cr | ₹699 Cr | ₹812 Cr |
What is the latest Total Non-Current Assets ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹584 Cr |
| Mar2025 | ₹557 Cr |
| Mar2024 | ₹612 Cr |
| Mar2023 | ₹699 Cr |
| Mar2022 | ₹812 Cr |
How is Total Non-Current Assets of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹584 Cr | 4.76 | |
| Mar2025 | ₹557 Cr | -8.92 | |
| Mar2024 | ₹612 Cr | -12.43 | |
| Mar2023 | ₹699 Cr | -13.95 | |
| Mar2022 | ₹812 Cr | - | |
Compare Total Non-Current Assets of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹42,361.9 Cr | 0.7% | -9.3% | -3.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 0.7% |
-9.3% |
-3.3% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses